< Back to previous page
Researcher
Wim Robberecht
- Disciplines:Neurosciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Laboratory for Neurobiology (VIB-KU Leuven) (Lab)
Member
From1 Jan 2012 → Today - Research Group Experimental Neurology (Division)
Member
From1 Oct 1999 → 31 Dec 2011
Projects
1 - 10 of 29
- Identification, characterization and validation of modifiers of repeat RNA toxicity in C9orf72 amyotrophic lateral sclerosis (ALS)From1 Oct 2018 → 28 Feb 2023Funding: FWO fellowships
- Clin-IC: Medtech solutions for patientsFrom1 May 2018 → TodayFunding: IOF - mandates, IOF - Industrial Research Fund
- Investigating modifiers of C9orf72 induced pathology in Amyotrophic Lateral Sclerosis (ALS) using zebrafish.From1 Jan 2017 → 31 Dec 2019Funding: Foundations, funds and other with scientific goal
- Investigating modifiers of C9orf72 induced pathology in Amyotrophic Lateral Sclerosis (ALS) using zebrafish.From1 Oct 2014 → 30 Sep 2018Funding: FWO fellowships
- The role of EphA4 in neural repair following ischemic strokeFrom1 Apr 2014 → 16 Mar 2020Funding: BOF - Doctoral projects, FWO fellowships
- JP ND-ALS-CarE : A programme for ALS Care in Europe.From1 Feb 2014 → 31 Jan 2019Funding: FWO research project (including WEAVE projects)
- Identifying COL4A1 and COL4A2 mutations in sporadic cerebral white matter diseaseFrom1 Jan 2014 → 31 Dec 2014Funding: FWO research grant KAN
- The ephrin axon repellent system in amyotrophic lateral sclerosis (ALS).From1 Jan 2014 → 31 Dec 2016Funding: Foundations, funds and other with scientific goal
- The ephrin axonal repellent system in Amyotrophic Lateral Sclerosis.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- The mechanism of mutant C9orf72 in the pathogenesis of Amyotrophic Lateral Sclerosis/Frontotemporal Lobe Degeneration.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 198
- The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases(2023)
Authors: Wim Robberecht
- Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence data(2022)
Authors: Wim Robberecht, Philip Van Damme
- The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration(2022)
Authors: Wim Robberecht, Philip Van Damme
- Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis(2022)
Authors: Wim Robberecht, Philip Van Damme
- The Effect of SMN Gene Dosage on ALS Risk and Disease Severity(2021)
Authors: Wim Robberecht, Philip Van Damme
Pages: 686 - 697 - AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS(2021)
Authors: Elisabeth Rossaert, Sebastian Munck, Philip Van Damme, Matthew Holt, Ludo Van Den Bosch, Wim Robberecht
Pages: 508 - 519 - STING-Induced Inflammation - A Novel Therapeutic Target in ALS?(2021)
Authors: Philip Van Damme, Wim Robberecht
Pages: 765 - 767 - SCFD1 expression quantitative trait loci in amyotrophic lateral sclerosis are differentially expressed(2021)
Authors: Philip Van Damme, Wim Robberecht
- Exploration of the role of EphA4 in neurodegenerative diseases.(2020)
Authors: Lindsay Poppe, Wim Robberecht, Philip Van Damme
- Environmental enrichment during the chronic phase after experimental stroke promotes functional recovery without synergistic effects of EphA4 targeted therapy(2020)
Authors: Lindsay Poppe, Wim Robberecht, Robin Lemmens
Pages: 605 - 617
Patents
1 - 6 of 6
- Single domain antibodies against sod1 and their use in medicine (Inventor)
- Hdac inhibitors to treat charcot-marie-tooth disease (Inventor)
- SINGLE DOMAIN ANTIBODIES AGAINST SOD1 AND THEIR USE IN MEDICINE (Inventor)
- HDAC inhibitors to treat charcot-marie-tooth disease (Inventor)
- SINGLE DOMAIN ANTIBODIES AGAINST SOD1 AND THEIR USE IN MEDICINE (Inventor)
- USE OF EPHRIN TYPE-A RECEPTOR 4 SIGNALING INHIBITOR FOR TREATMENT OF MOTOR NEURON DISEASE CHOSEN FROM AMYOTROPHIC LATERAL SCLEROSIS AND SPINAL MUSCULAR ATROPHY (Inventor)